ACE2 and COVID-19: It is thus plausible that supplemental oxygen treatment during early stages of COVID-19 could up-regulate ACE2 expression in the lower airways, which may not be captured in autopsy specimens due to diffuse lung damage with loss of AT2s and bronchial epithelial cells.